11Beta-hydroxysteroid dehydrogenase-type 2 evolved from an ancestral 17beta-hydroxysteroid dehydrogenase-type 2
1Department of Medicine, 0693, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0693, United States. mbaker@ucsd.edu
Biochemical and Biophysical Research Communications
|July 27, 2010
Summary
The evolution of 11beta-hydroxysteroid dehydrogenase-type 2 (11beta-HSD2) and 17beta-HSD2 enzymes was investigated using genomic data. Ancestral 17beta-HSD2 appeared early in deuterostomes, while 11beta-HSD2 emerged later in sharks.
Area of Science:
- Biochemistry
- Evolutionary Biology
- Genomics
Background:
- 11beta-hydroxysteroid dehydrogenase-type 2 (11beta-HSD2) and 17beta-HSD2 are paralogous enzymes regulating steroid hormone concentrations.
- These enzymes are crucial for activating glucocorticoid, mineralocorticoid, androgen, and estrogen receptors.
- The evolutionary origins and divergence of 11beta-HSD2 and 17beta-HSD2 remain largely unknown.
Purpose of the Study:
- To investigate the evolutionary origins and early divergence of 11beta-HSD2 and 17beta-HSD2.
- To utilize genomic data from basal deuterostomes and chordates to trace the evolutionary history of these enzymes.
Main Methods:
- Bioinformatic analyses, including BLAST searches, were performed on genomic sequences from sea urchin, acorn worm, amphioxus, and elephant shark.
- Phylogenetic analyses were conducted to infer the evolutionary relationships and identify ancestral sequences.
Main Results:
- An ancestral 17beta-HSD2 sequence was identified in early deuterostomes (sea urchin, acorn worm, amphioxus).
- An ancestral 11beta-HSD2 sequence was first detected in sharks, indicating a later evolutionary appearance.
- Sequence analyses suggest potential non-enzymatic activity for sea urchin 17beta-HSD2 and novel substrate metabolism for acorn worm 17beta-HSD2 if catalytically active.
Conclusions:
- 17beta-HSD2 likely predates 11beta-HSD2, with its origins traceable to early deuterostomes.
- The emergence of 11beta-HSD2 appears to have occurred later in vertebrate evolution, specifically by the shark lineage.
- Early 17beta-HSD2 enzymes may have possessed different functional properties, including potential non-enzymatic roles or novel substrate specificities.
Related Concept Videos
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Intracellular Hormone Receptors
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

